Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jan 11, 2007

Bio-Rad Obtains License to Axis-Shield’s RA Test

  • Bio-Rad gained access to Axis-Shield's test for the early detection of rheumatoid arthritis. The assay will run on Bio-Rad's BioPlex® 2200 system and will test for anticyclic citrullinated peptide antibodies.

    "The ability to incorporate an anti-CCP test as part of a rheumatoid arthritis panel will add significantly to our growing menu of autoimmune tests on the BioPlex 2200 system," points out John Goetz, Bio-Rad vp and group manager of clinical diagnostics. "As the first and only fully automated, random access multiplex testing platform, the BioPlex 2200 system is ideally suited as a platform for multimarker autoimmune testing that includes rheumatoid arthritis."



Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »